PROTECTIVE EFFECTS OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA AND INTERFERON-GAMMA AGAINST SURGICALLY SIMULATED WOUND-INFECTION IN MICE

被引：20
作者：
HERSHMAN, MJ
PIETSCH, JD
TRACHTENBERG, L
MOONEY, THR
SHIELDS, RE
SONNENFELD, G
机构：
[1] UNIV LOUISVILLE,SCH MED,DEPT MICROBIOL & IMMUNOL,LOUISVILLE,KY 40292
[2] UNIV LOUISVILLE,SCH MED,DEPT ORAL HLTH,LOUISVILLE,KY 40292
[3] UNIV LOUISVILLE,SCH DENT,LOUISVILLE,KY 40292
[4] UNIV LOUISVILLE,PRICE INST SURG RES,DEPT SURG,LOUISVILLE,KY 40292
来源：
BRITISH JOURNAL OF SURGERY | 1989年 / 76卷 / 12期
关键词：
D O I：
10.1002/bjs.1800761220
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1282 / 1286
页数：5
相关论文
共 25 条
  • [1] PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN
    BEUTLER, B
    MILSARK, IW
    CERAMI, AC
    [J]. SCIENCE, 1985, 229 (4716) : 869 - 871
  • [2] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
  • [3] CAMPBELL JB, 1975, CAN J MICROBIOL, V21, P147
  • [4] CLINICAL-PHARMACOLOGY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR IN PATIENTS WITH ADVANCED CANCER
    CHAPMAN, PB
    LESTER, TJ
    CASPER, ES
    GABRILOVE, JL
    WONG, GY
    KEMPIN, SJ
    GOLD, PJ
    WELT, S
    WARREN, RS
    STARNES, HF
    SHERWIN, SA
    OLD, LJ
    OETTGEN, HF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) : 1942 - 1951
  • [5] BIOLOGICAL-ACTIVITY OF A NEW SYNTHETIC MURAMYL PEPTIDE ADJUVANT DEVOID OF PYROGENICITY
    CHEDID, LA
    PARANT, MA
    AUDIBERT, FM
    RIVEAU, GJ
    PARANT, FJ
    LEDERER, E
    CHOAY, JP
    LEFRANCIER, PL
    [J]. INFECTION AND IMMUNITY, 1982, 35 (02) : 417 - 424
  • [6] COLEMAN RJ, 1987, AM SURGEON, V53, P584
  • [7] RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR INCREASES MESSENGER-RNA LEVELS AND SURFACE EXPRESSION OF HLA-A,B ANTIGENS IN VASCULAR ENDOTHELIAL-CELLS AND DERMAL FIBROBLASTS INVITRO
    COLLINS, T
    LAPIERRE, LA
    FIERS, W
    STROMINGER, JL
    POBER, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) : 446 - 450
  • [8] DEMAEYER E, 1984, INTERFERONS IMMUNE S, P1
  • [9] A PHASE-I TRIAL OF INTRAVENOUSLY-ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN CANCER-PATIENTS
    FEINBERG, B
    KURZROCK, R
    TALPAZ, M
    BLICK, M
    SAKS, S
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) : 1328 - 1334
  • [10] FIERS W, 1985, BIOL INTERFERON SYST, P241
123